[Pharmacological analysis of a specific cholinacetylase inhibitor].
D000217:Acyltransferases / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D000818:Animals; D002490:Central Nervous System / Q000187:drug effects*; D002712:Chlorides / Q000494:pharmacology; D002800:Cholinesterase Inhibitors; D004357:Drug Synergism; D005260:Female; D008238:Lysergic Acid Diethylamide; D008297:Male; D051379:Mice; D009281:Naphthalenes / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology*; D014202:Tremor / Q000139:chemically induced / Q000188:drug therapy; D014203:Tremorine; D014753:Vinyl Compounds / Q000494:pharmacology
D002712:Chlorides; D002800:Cholinesterase Inhibitors; D009281:Naphthalenes; D011725:Pyridines; D014753:Vinyl Compounds; D008238:Lysergic Acid Diethylamide; D000217:Acyltransferases; D014203:Tremorine
Pharmakologische Analyse eines spezifischen Cholinacetylase-Inhibitors.